Staidson BioPharmaceuticals Co., Ltd. amended terms of the transaction
On August 9, 2023, the company announced that the application for the issuance of the shares has been approved by the Shenzhen Stock Exchange?s Listing Review Center.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.3 CNY | -2.17% | +11.50% | -37.99% |
1st Jan change | Capi. | |
---|---|---|
-37.99% | 415M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |